Skip to content

Home
Stock Stories
US Equities
Ticker Update
Equity Analysis

Menu

Home
Stock Stories
US Equities
Ticker Update
Equity Analysis

ABCL

Tag
ABCL

Finance

AbCellera Biologics Inc. [ABCL] moved up 5.40: Why It’s Important

Misty Lee June 30, 2021

Industry

AbCellera Biologics Inc. [ABCL] fell -40.76% so far this year. What now?

Edison Baldwin June 10, 2021

Industry

AbCellera Biologics Inc. [ABCL] Revenue clocked in at $218.20 million, down -32.53% YTD: What’s Next?

Misty Lee May 28, 2021

Industry

SVB Leerink lifts AbCellera Biologics Inc. [ABCL] price estimate. Who else is bullish?

Brandon Evans May 5, 2021

Industry

why AbCellera Biologics Inc. [ABCL] is a Good Choice for Investors After New Price Target of $52.40

Misty Lee April 8, 2021

Market

AbCellera Biologics Inc. [ABCL] Stock trading around $26.68 per share: What’s Next?

Brandon Evans March 31, 2021

Industry

why AbCellera Biologics Inc. [ABCL] is a Good Choice for Investors After New Price Target of $55.80

Edison Baldwin March 19, 2021

Market

AbCellera Biologics Inc. [ABCL] gain 10.36% so far this year. What now?

Misty Lee January 18, 2021

Finance

AbCellera Biologics Inc. [ABCL] stock Initiated by SVB Leerink analyst, price target now $45

Misty Lee January 14, 2021

Market

Market cap of AbCellera Biologics Inc. [ABCL] reaches 11.34B – now what?

Caleb Clifford December 24, 2020

Company

HomePage
About US
Our Team
Contact US
STOCK STORIES

Categories

Companies
Equity Analysis
Finance
Market
Stock Stories

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Email

© DBT NEWS. All rights reserved.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

About Us
Contact Us
Homepage
Our Team
Thank You